Everything below concerns reversed-phase chromatography. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-06-11. Where a claim depends on a specific study, the study is described rather than over-claimed.
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
| Property | Value | Notes |
|---|---|---|
| Reported sequence | Ac-LKKTETQ | Described in most listings as the actin-binding region of thymosin beta-4 |
| Reported molecular weight | Approximately 889 Da | Value shifts with the stated sequence; compare against the certificate of analysis |
| Parent protein length | 43 amino acids | Thymosin beta-4; the fragment covers only a small part of it |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Trade-style names rather than formal nomenclature |
| Formal monographs | Not established | Labeling conventions differ by supplier and region |
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
=== Legal status === In May 1987, the US Food and Drug Administration (FDA) requested additional data for the drug rather than approve it outright, causing Genentech stock prices to fall by nearly one quarter. The decision was described as a surprise to the company as well as many cardiologists and regulators, and it generated significant criticism of the FDA. After results from two additional trials were obtained, Alteplase was approved for medical use in the United States in November 1987 for the treatment of myocardial infarction. This was just seven years after the first efforts were made to produce recombinant t-PA, making it one of the fastest drug developments in history.
=== Regulatory gaps and the absence of statutory safeguards === A central criticism of UK AI policy is that its light-touch, pro-innovation regulatory stance leaves the public inadequately protected from AI-related harms. The Ada Lovelace Institute, an independent research body, has argued that the UK "lacks a comprehensive legal framework to govern AI systems" and that many harmful AI capabilities "arise during the design and development of AI systems — where few rules apply and few regulators have oversight". The Institute has called for a statutory AI Bill that mandates pre-deployment testing for general-purpose AI systems, empowers regulators to withdraw unsafe models from the UK market, and requires developers to disclose known risks, environmental impacts, and mitigation measures. Research published by the Ada Lovelace Institute in December 2025, based on a nationally representative poll, found that 89% of the UK public support the establishment of an independent regulator for AI equipped with enforcement powers, and that 91% believe it is important that AI systems are developed and used in ways that treat people fairly. Critically, 84% of respondents feared that the government would prioritise its partnerships with large technology companies over the public interest when regulating AI. The Institute's UK Public Policy Lead, Nuala Polo, stated: "Our research is clear: there is a major misalignment between what the UK public want and what the government is offering in terms of AI regulation."
Clinical psychology is an integration of human science, behavioral science, theory, and clinical knowledge aimed at understanding, preventing, and relieving psychological distress or dysfunction as well as promoting well-being and personal growth. Central to its practice are psychological assessment, diagnosis, clinical formulation, and psychotherapy; although clinical psychologists also engage in research, teaching, consultation, forensic testimony, and program development and administration. In many countries, clinical psychology is a regulated mental health profession. In the United States, clinical psychologists operate under the same license as counseling psychologists and school psychologists. The field is generally considered to have begun in 1896 with the opening of the first psychological clinic at the University of Pennsylvania by Lightner Witmer. In the first half of the 20th century, clinical psychology was focused on psychological assessment, with little attention given to treatment. This changed after the 1940s when World War II resulted in the need for a large increase in the number of trained clinicians. Since that time, three main educational models have developed in the US—the PhD Clinical Science model (heavily focused on research), the PhD science-practitioner model (integrating scientific research and practice), and the PsyD practitioner-scholar model (focusing on clinical theory and practice).
Sources: en.wikipedia.org
Mirtazapine is sometimes described as a noradrenergic and specific serotonergic antidepressant (NaSSA), although the actual evidence in support of this label has been regarded as poor. It is a tetracyclic piperazine-azepine. Mirtazapine has antihistamine, α2-blocker, and antiserotonergic activity. It is specifically a potent antagonist or inverse agonist of the α2A-, α2B-, and α2C-adrenergic receptors, the serotonin 5-HT2A, 5-HT2C, and the histamine H1 receptor. Unlike many other antidepressants, it does not inhibit the reuptake of serotonin, norepinephrine, or dopamine, nor does it inhibit monoamine oxidase. Similarly, mirtazapine has weak or no activity as an anticholinergic or blocker of sodium or calcium channels, in contrast to most tricyclic antidepressants. In accordance, it has better tolerability and low toxicity in overdose. As an H1 receptor antagonist, mirtazapine is extremely potent, and is in fact one of the most potent H1 receptor inverse agonists among tricyclic and tetracyclic antidepressants and most antihistamines in general. Antagonism of the H1 receptor is by far the strongest activity of mirtazapine, with the drug acting as a selective H1 receptor antagonist at low concentrations. The (S)-(+) enantiomer of mirtazapine is responsible for antagonism of the serotonin 5-HT2A and 5-HT2C receptors, while the (R)-(–) enantiomer is responsible for antagonism of the 5-HT3 receptor. Both enantiomers are involved in antagonism of the H1 and α2-adrenergic receptors, although the (S)-(+) enantiomer is the stronger antihistamine.
The lowest temperatures on record in most cities in the eastern United States were set after a mass of cold air came south from Canada. Record lows ranged from International Falls, Minnesota −45 °F (−43 °C) to Washington, D.C. and Jackson, Mississippi−5 °F (−21 °C), and were set in Milwaukee −26 °F (−32 °C), Pittsburgh −18 °F (−28 °C) and Cleveland −17 °F (−27 °C) Winston Cenac resigned as Prime Minister of Saint Lucia after 8 months in office, and was succeeded temporarily by Finance Minister Michael Pilgrim. Born: Dwyane Wade, American NBA player and team owner, 2006 MVP of the NBA Finals for the Miami Heat, inductee to the Basketball Hall of Fame, and later a minority owner of the Utah Jazz and the WNBA Chicago Sky; in Chicago Died: Varlam Shalamov, Russian writer known for Kalyma's Notes, an exposure of the horrors of Soviet labor camps, where he had been incarcerated from 1937 to 1954 Jusuf Gërvalla, 38, Albanian-born Yugoslavian Kosovo independence activist and founder of a Yugoslavian separatist group, the National Movement for the Liberation of Kosovo, was shot to death in West Germany by Yugoslavia's State Security Service. He, his brother Bardhosh Gërvalla, and another activist, Kadri Zeka, were sitting in a car in the town of Untergruppenbach when all three were killed. William Price, 86, British World War One flying ace with seven shootdowns Pierre De Cazenove De Pradines, 87, French flying ace in World War One with seven aerial victories.
Smooth muscle cell proliferation is one of important mechanisms of hypertensive remodeling of blood vessels and their stenosis, so it is an important pathogenetic mechanism in arterial hypertension and atherosclerosis. Endogenous sulfur dioxide in low concentrations causes endothelium-dependent vasodilation. In higher concentrations it causes endothelium-independent vasodilation and has a negative inotropic effect on cardiac output function, thus effectively lowering blood pressure and myocardial oxygen consumption. The vasodilating and bronchodilating effects of sulfur dioxide are mediated via ATP-dependent calcium channels and L-type ("dihydropyridine") calcium channels. Endogenous sulfur dioxide is also a potent antiinflammatory, antioxidant and cytoprotective agent. It lowers blood pressure and slows hypertensive remodeling of blood vessels, especially thickening of their intima. It also regulates lipid metabolism. Endogenous sulfur dioxide also diminishes myocardial damage, caused by isoproterenol adrenergic hyperstimulation, and strengthens the myocardial antioxidant defense reserve.
Sources: en.wikipedia.org
The Wall Street Journal reported that several US Navy destroyers entered the Strait of Hormuz for the first time since the war began. A US official described the event as an "operation that focused on freedom of navigation through International waters”. Iranian government reportedly threatened to attack the ships, accusing US of ceasefire violation. US CENTCOM said the ships are taking part in mine clearance operations. JD Vance announced that the talks between the US and Iran had failed, as he was unable to reach an agreement after a day of negotiations. Afterwards, Trump declared a naval blockade on the Strait of Hormuz, announcing that the US Navy will prevent ships from entering or exiting the Strait and intercept vessels that have paid tolls to Iran. US CENTCOM announced that the blockade will be enforced on vessels of all nations entering or departing Iranian ports and coastal areas but "will not impede freedom of navigation for vessels transiting the Strait of Hormuz to and from non-Iranian ports." The IRGC Navy said that any military vessel approaching the strait would be considered a ceasefire violation and would meet a "severe response." On 21 April, US Senator Lindsey Graham praised the decision to leave the naval blockade in place, saying that it will be a source of pressure for the Iranian government. He also set out strict conditions for any potential agreement with Iran. On 12 May, ahead of his state visit to China, Trump was asked by a reporter about the extent to which he cared about Americans' financial situations while in negotiations with Iran.
In January 2023, US president Joe Biden invited Lula to meet him in Washington, D.C., in February 2023 following a phone conversation between them on the 2023 Brazilian Congress attack. White House press secretary Karine Jean-Pierre confirmed the meeting adding that it would address "U.S. support of Brazil's democracy and how the two countries can continue to work together to promote inclusion and democratic values in the region and around the world". Climate change, migration, economic development and security matters were also discussed. In February 2023, Lula and a delegation including his Foreign Affairs special advisor Celso Amorim, Foreign minister Mauro Vieira, Finance minister Fernando Haddad, Racial Equality minister Anielle Franco, Environment e Climate Justice minister Marina Silva travelled to the US. During the trip Lula met with US Senator Bernie Sanders, Democratic House Representatives Alexandria Ocasio-Cortez, Pramila Jayapal, Sheila Jackson Lee, Brad Sherman and Ro Khanna before he met with US president Joe Biden at the White House. On 10 February, at a meeting with American president Joe Biden, Lula proposed the creation of a group of negotiators made up of countries "not involved in the war" (either directly or indirectly, i.e.
== Antisense oligonucleotide development == Developments in ASO modification are separated into three generations. Generation one is called backbone-modified and focuses on the phosphodiester group of the nucleotide. This impacts inter-nucleotide binding. These modifications led to better distribution, reduced urinary excretion, and prolonged residence time of the ASOs in the cell. Some examples of first generation modifications include the addition of a phosphorothioate group (PS), methyl group, or nitrogen. The most common is the phosphorothioate group (PS) in which the oxygen atoms of a phosphodiester group are replaced with sulfur atoms, greatly improving efficacy and reducing degradation. Generation two is sugar-modified, focused on the ribose sugar of the nucleotide. This generation saw improved binding affinity while reducing degradation. Some examples of generation two modifications are the substitution of R group with morpholine group (MO) and the usage of phosphorodiamidate morpholino oligomer (PMO) and thiomorpholine oligomer (TMO) as linkages between the ribose sugar and phosphodiester group in the backbone. Generation three is nucleobase-modified, the least common type of modification. These modifications enhanced binding affinity and cell penetration while reducing degradation and off-target effects. Examples include the introduction of G-clamps, pseudoisocytosine, and the substitution of bases with amine, thione, halogen, alkyl, alkenyl, or alkynyl groups.
== Biosynthesis == In Aspergillus fumigatus, the enzymes needed for gliotoxin biosynthesis are encoded in 13 genes within the gli gene cluster. When this gene cluster is activated, these enzymes mediate the production of gliotoxin from serine and phenylalanine residues. The function of some genes contained within the gli gene cluster remain to be elucidated. Enzymes Involved in Biosynthesis (in order of activity)
Sources: en.wikipedia.org
Most listings describe it as a short acetylated peptide with the sequence Ac-LKKTETQ, presented as a region of thymosin beta-4. The label is a trade-style name rather than a standardized chemical name, so the exact content of a given vial depends on the supplier.
No. Thymosin beta-4 is a protein of 43 amino acids, while TB-500 is described as a short fragment of it. The two differ in size, structure, and the range of interactions each can support.
Naming for research peptides is not centrally coordinated, so vendors set their own labels and specifications. Differences in stated sequence, molecular weight, or purity documentation usually trace back to those independent labeling choices.
The lyophilised powder is typically held at -20 C or lower in a dry, dark place. Reconstituted solutions are aliquoted and frozen to avoid repeated freeze-thaw cycles.